Home > Qtrly Results > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Quarterly Results Analysis [Dec2023]

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Quarterly Results

Consolidated Dec2023
Audited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹61 Cr ₹55 Cr ₹66 Cr ₹81 Cr ₹87 Cr ₹86 Cr ₹83 Cr ₹89 Cr
Expenses ₹47 Cr ₹44 Cr ₹57 Cr ₹68 Cr ₹71 Cr ₹72 Cr ₹69 Cr ₹78 Cr
Operating Income ₹14 Cr ₹11 Cr ₹9 Cr ₹13 Cr ₹15 Cr ₹15 Cr ₹14 Cr ₹11 Cr
Other Income ₹0 Cr ₹0 Cr ₹-1 Cr ₹0 Cr ₹-5 Cr ₹4 Cr ₹3 Cr ₹4 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹0 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Profit Before Tax ₹14 Cr ₹16 Cr ₹-39 Cr ₹11 Cr ₹11 Cr ₹19 Cr ₹17 Cr ₹15 Cr
Profit After Tax ₹14 Cr ₹14 Cr ₹-41 Cr ₹8 Cr ₹8 Cr ₹15 Cr ₹14 Cr ₹13 Cr
EPS ₹13.29 ₹14.10 ₹-40.41 ₹7.96 ₹8.21 ₹15.49 ₹14.15 ₹12.71
Industry Peers & Returns1W1M1Y
BALAXI PHARMACEUTICALS -3.3% -20% -5.4%
ADANI ENTERPRISES 1.8% -4.9% 70.2%
REDINGTON 2.5% -1.3% 27%
HONASA CONSUMER NA NA NA
MMTC 1.5% -21.7% 117.1%
MSTC 1.9% -10.7% 225.8%
LLOYDS ENTERPRISES NA NA NA
VERITAS (INDIA) 8.2% 40.5% 537.8%
NOVARTIS INDIA 3.9% 2.7% 80.7%

BALAXI PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

11.08 %

Y-o-Y

-29.79 %

Quarters Revenues % Change
Dec2023 ₹61 Cr
11.08
Sep2023 ₹55 Cr
-17.03
Jun2023 ₹66 Cr
-18.25
Mar2023 ₹81 Cr
-6.82
Dec2022 ₹87 Cr
0.23
Sep2022 ₹86 Cr
4.35
Jun2022 ₹83 Cr
-7.09
Mar2022 ₹89 Cr -

BALAXI PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

26.90 %

Y-o-Y

-10.67 %

Quarters Operating Profit % Change
Dec2023 ₹14 Cr
26.90
Sep2023 ₹11 Cr
21.75
Jun2023 ₹9 Cr
-30.62
Mar2023 ₹13 Cr
-16.68
Dec2022 ₹15 Cr
3.65
Sep2022 ₹15 Cr
7.31
Jun2022 ₹14 Cr
22.45
Mar2022 ₹11 Cr -
Operating Margins
Q-o-Q

14.23 %

Y-o-Y

27.24 %

Quarters Operating Margin% % Change
Dec2023 22.47%
14.23
Sep2023 19.67%
46.79
Jun2023 13.4%
-15.14
Mar2023 15.79%
-10.59
Dec2022 17.66%
3.40
Sep2022 17.08%
2.83
Jun2022 16.61%
31.83
Mar2022 12.6% -

BALAXI PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-5.79 %

Y-o-Y

65.20 %

Quarters Profit After Tax % Change
Dec2023 ₹14 Cr
-5.79
Sep2023 ₹14 Cr
Positive
Jun2023 ₹-41 Cr
Negative
Mar2023 ₹8 Cr
-1.59
Dec2022 ₹8 Cr
-46.86
Sep2022 ₹15 Cr
9.46
Jun2022 ₹14 Cr
11.31
Mar2022 ₹13 Cr -
PAT Margins
Q-o-Q

-15.21 %

Y-o-Y

135.37 %

Quarters PAT Margin(%) % Change
Dec2023 22.36 %
-15.21
Sep2023 26.37 %
Positive
Jun2023 -62.68 %
Negative
Mar2023 10.04 %
5.68
Dec2022 9.5 %
-47.02
Sep2022 17.93 %
4.92
Jun2022 17.09 %
19.76
Mar2022 14.27 % -

BALAXI PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-5.74 %

Y-o-Y

61.88 %

Quarters EPS % Change
Dec2023 ₹13.29
-5.74
Sep2023 ₹14.1
Positive
Jun2023 ₹-40.41
Negative
Mar2023 ₹7.96
-3.05
Dec2022 ₹8.21
-47.00
Sep2022 ₹15.49
9.47
Jun2022 ₹14.15
11.33
Mar2022 ₹12.71 -

You may also like the below Video Courses